Hennion & Walsh Asset Management, Inc. Sarepta Therapeutics, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$117.53 - $155.99 $65,934 - $87,510	-561 Reduced 3.31%	16,385 $2.26 Million
Q4 2022 Jan 12, 2023	BUY	$100.86 - $132.13 $216,042 - $283,022	2,142 Added 14.47%	16,946 $2.2 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $15,520 - $24,444	-205 Reduced 1.37%	14,804 $1.64 Million
Q2 2022 Jul 19, 2022	SELL	$62.69 - $88.44 $13,979 - $19,722	-223 Reduced 1.46%	15,009 $1.13 Million
Q1 2022 Apr 26, 2022	BUY	$63.15 - $90.42 $19,639 - $28,120	311 Added 2.08%	15,232 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $72,102 - $92,758	933 Added 6.67%	14,921 $1.34 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $315,996 - $442,979	4,790 Added 52.08%	13,988 $1.29 Million
Q2 2021 Aug 13, 2021	BUY	$69.38 - $86.75 $638,157 - $797,926	9,198 New	9,198 $715,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.